Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
doi: 10.2147/ijn.s273713 Summary Keywords immunosuppression, immunotherapy resistance, nanomedicine delivery systems, osteosarcoma, translational oncology, tumor microenvironment (TME) Citation Huang Q, Yu G, Shi B and Deng T (2026) Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion
There is no rebound
M., Flower, R
Biochimica et Biophysica Acta (BBA) - General Subjects
P., & Meyskens, F
One major obstacle is the heterogeneity of MDSCs, which complicates targeting efforts as monocytic and granulocytic subsets have distinct immunosuppressive mechanisms
US$ 23.23
US$ 26.88
.png)
%20(1).png)
US$ 27.78
US$ 26.41
US$ 22.67
US$ 28.04
